SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-259396
Filing Date
2011-09-29
Accepted
2011-09-29 09:19:29
Documents
44
Period of Report
2011-09-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d237073d8k.htm 8-K 15235
2 CORPORATE OVERVIEW PRESENTATION SLIDES d237073dex991.htm EX-99.1 156911
3 GALECTIN THERAPEUTICS INC. PRESS RELEASE DATED SEPTEMBER 29, 2011 d237073dex992.htm EX-99.2 10689
4 GRAPHIC g237073ex99_1s10gbgd.jpg GRAPHIC 37286
5 GRAPHIC g237073ex99_1s11gbgd.jpg GRAPHIC 33311
6 GRAPHIC g237073ex99_1s12g1.jpg GRAPHIC 4815
7 GRAPHIC g237073ex99_1s12g2.jpg GRAPHIC 4815
8 GRAPHIC g237073ex99_1s12gbgd.jpg GRAPHIC 50692
9 GRAPHIC g237073ex99_1s13gbgd.jpg GRAPHIC 30458
10 GRAPHIC g237073ex99_1s14gbgd.jpg GRAPHIC 22569
11 GRAPHIC g237073ex99_1s15gbgd.jpg GRAPHIC 74345
12 GRAPHIC g237073ex99_1s16gbgd.jpg GRAPHIC 22569
13 GRAPHIC g237073ex99_1s17gbgd.jpg GRAPHIC 22569
14 GRAPHIC g237073ex99_1s18gbgd.jpg GRAPHIC 61364
15 GRAPHIC g237073ex99_1s19gbgd.jpg GRAPHIC 34156
16 GRAPHIC g237073ex99_1s1gbgd.jpg GRAPHIC 44171
17 GRAPHIC g237073ex99_1s20gbgd.jpg GRAPHIC 33696
18 GRAPHIC g237073ex99_1s21gbgd.jpg GRAPHIC 68275
19 GRAPHIC g237073ex99_1s22gbgd.jpg GRAPHIC 33931
20 GRAPHIC g237073ex99_1s23gbgd.jpg GRAPHIC 80884
21 GRAPHIC g237073ex99_1s24gbgd.jpg GRAPHIC 22569
22 GRAPHIC g237073ex99_1s25gbgd.jpg GRAPHIC 22569
23 GRAPHIC g237073ex99_1s26gbgd.jpg GRAPHIC 32781
24 GRAPHIC g237073ex99_1s27gbgd.jpg GRAPHIC 79813
25 GRAPHIC g237073ex99_1s28gbgd.jpg GRAPHIC 55631
26 GRAPHIC g237073ex99_1s29gbgd.jpg GRAPHIC 67126
27 GRAPHIC g237073ex99_1s2gbgd.jpg GRAPHIC 22569
28 GRAPHIC g237073ex99_1s30gbgd.jpg GRAPHIC 22569
29 GRAPHIC g237073ex99_1s31gbgd.jpg GRAPHIC 58326
30 GRAPHIC g237073ex99_1s32gbgd.jpg GRAPHIC 67323
31 GRAPHIC g237073ex99_1s33gbgd.jpg GRAPHIC 42059
32 GRAPHIC g237073ex99_1s34gbgd.jpg GRAPHIC 22569
33 GRAPHIC g237073ex99_1s35gbgd.jpg GRAPHIC 105635
34 GRAPHIC g237073ex99_1s36gbgd.jpg GRAPHIC 22569
35 GRAPHIC g237073ex99_1s37gbgd.jpg GRAPHIC 22569
36 GRAPHIC g237073ex99_1s38gbgd.jpg GRAPHIC 41381
37 GRAPHIC g237073ex99_1s3gbgd.jpg GRAPHIC 22569
38 GRAPHIC g237073ex99_1s4gbgd.jpg GRAPHIC 22569
39 GRAPHIC g237073ex99_1s5gbgd.jpg GRAPHIC 52226
40 GRAPHIC g237073ex99_1s6gbgd.jpg GRAPHIC 42236
41 GRAPHIC g237073ex99_1s7gbgd.jpg GRAPHIC 43190
42 GRAPHIC g237073ex99_1s8gbgd.jpg GRAPHIC 24317
43 GRAPHIC g237073ex99_1s9gbgd.jpg GRAPHIC 22569
44 GRAPHIC g237073g20s53.jpg GRAPHIC 3836
  Complete submission text file 0001193125-11-259396.txt   2397186
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 111113453
SIC: 2834 Pharmaceutical Preparations